Clincosm LogoSign in Get a demo

Refractory Acute Myeloid Leukemia

Showing 26 - 50 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Gemtuzumab Ozogamicin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (8-Chloroadenosine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

Completed
Has Results
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Columbus, Ohio
  • +2 more
Aug 10, 2022

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)

Completed
  • Refractory Acute Myeloid Leukemia
  • Sequential Packaging (SET)
  • +4 more
  • Paris, France
    Service d'hématologie Clinique Hôpital Saint Antoine
Jul 22, 2022

AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

Recruiting
  • AML, Adult
  • +3 more
  • Shreveport, Louisiana
  • +3 more
Jul 19, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed
  • Relapsed Acute Myeloid Leukemia
  • +3 more
  • VAH regimen
  • VEN+HMA regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Duarte, California
  • +10 more
Jul 2, 2022

Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)

Recruiting
  • Relapsed Pediatric ALL
  • +3 more
  • Kansas City, Missouri
    Children's Mercy Hospital
Jul 1, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Cobimetinib, Enasidenib Mesylate)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)

Not yet recruiting
  • Refractory Acute Myeloid Leukemia
  • Relapsed Acute Myeloid Leukemia
  • Cytokine induced memory-like NK cells
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 30, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Refractory Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Kansas City, Baltimore (Fosciclopirox,

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Kansas City, Kansas
  • +1 more
May 28, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Decitabine and Cedazuridine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 19, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022